You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Neuroprotective therapies for multiple sclerosis and other demyelinating diseases
|
|---|---|
| Published in |
Multiple Sclerosis and Demyelinating Disorders, April 2016
|
| DOI | 10.1186/s40893-016-0004-0 |
| Authors |
Pablo Villoslada |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Saudi Arabia | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 52 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 21% |
| Student > Master | 6 | 12% |
| Student > Doctoral Student | 5 | 10% |
| Other | 5 | 10% |
| Student > Bachelor | 4 | 8% |
| Other | 8 | 15% |
| Unknown | 13 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 21% |
| Biochemistry, Genetics and Molecular Biology | 6 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 10% |
| Neuroscience | 5 | 10% |
| Agricultural and Biological Sciences | 3 | 6% |
| Other | 7 | 13% |
| Unknown | 15 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2016.
All research outputs
#12,756,718
of 22,860,626 outputs
Outputs from Multiple Sclerosis and Demyelinating Disorders
#9
of 22 outputs
Outputs of similar age
#134,177
of 300,229 outputs
Outputs of similar age from Multiple Sclerosis and Demyelinating Disorders
#2
of 2 outputs
Altmetric has tracked 22,860,626 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22 research outputs from this source. They receive a mean Attention Score of 3.3. This one scored the same or higher as 13 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 300,229 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.